PES2020-Prosj.etabl.støtte H2020
Project Establishment Support for EIC Accelerator application
AlgiPharma is developing a new drug, OligoG, for cystic fibrosis patients and are currently in phase 2b clinical trials with an inhalable formulation of OligoG. In order to get market approval to the American Market, an IND needs to be filed with the American Food and Drug Administration (FDA). T...